News for Mallinckrodt plc (MNK)

PR NewswireVANCOUVER, BC, June 18, 2025 USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, June 18, 2025 /PRNewswire/

Mallinckrodt's latest survey highlights high patient satisfaction with the Acthar Gel SelfJect injector. The survey reveals that patients find the devic

PR NewswireDUBLIN and MALVERN, Pa., June 9, 2025 Experienced and Highly Capable Senior Executives to Lead both the Branded Specialty Pharmaceutical and Gen

**media[641779]**

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of

Mallinckrodt's study shows Acthar Gel improved health status in 89% of lupus patients. 82% of patients reported overall symptom improvements, while 44%

Endo Inc's diverse portfolio and recent strategic moves position it for potential growth amidst industry challenges.Financial restructuring and a planned merge

PR NewswireMALVERN, Pa., May 7, 2025 XIAFLEX® revenues grew 7% compared to first-quarter 2024The Company reaffirms 2025 revenue guidance of $1,775 to $1,8

Mallinckrodt (MNK) reported Q1 2025 net sales of $419.9 million, marking a 10.2% decrease year-over-year, but excluding the Therakos divestiture, sales incre

NEW YORK, May 03, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of

PR NewswireWILMINGTON, Del., April 29, 2025 Matthew Harbaugh named Chief Financial Officer; management team fully staffed ahead of spin-offChange to future

Mallinckrodt to present five clinical studies on TERLIVAZ® (terlipressin) at Digestive Disease Week 2025. Research focuses on treating hepatorenal synd

Mallinckrodt plc (MNK) to announce Q1 2025 earnings on May 6, 2025. Investor conference call scheduled at 8:30 a.m. ET alongside the earnings release.

Transaction Overview On March 13, 2025, Silver Point Capital L.P. (Trades, Portfolio) executed a significant transaction by acquiring 1,692,330 shares of Mallin

On March 13, 2025, Hein Park Capital Management LP (Trades, Portfolio) made a notable move by acquiring 1,914,673 shares of Mallinckrodt PLC (MCKPF). This trans

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

Endo International plc (OTC:ENDPQ) Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ETCompany ParticipantsLaure Park - Senior Vice President of...

Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York Stock Exchange, the two drugmakers said Thursday.

PR NewswireMALVERN, Pa., March 13, 2025 Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic prioritiesX